Prenatal drug exposure and social policy: the search for an appropriate response.
Prenatal drug exposure continues to be a controversial topic. Views of what constitutes an appropriate response to drug-exposed infants vary, in large part due to the many complex issues endemic to perinatal substance use. The purpose of this article is to review the controversy surrounding prenatal drug exposure, outline the policy dilemmas that complicate attempts to respond appropriately, review current practice in this area and the effectiveness of those practices, and offer specific recommendations as a starting point for debate. It is suggested that earlier controversy regarding the sequelae of prenatal drug exposure may be decreasing as research identifies specific and subtle deficits in some affected infants. It is also suggested that the postnatal effects of parental substance abuse (e.g., in terms of abuse/neglect, attachment, and development) are the more appropriate focus of child protection efforts, and that different disciplines must collaborate to reach a consensus regarding the nature of these efforts.
University of Oklahoma Health Sciences Center, USA. s.ondersma@wayne.edu
S J
SJ
Ondersma
S M
SM
Simpson
E V
EV
Brestan
M
M
Ward
D002648:Child; D002655:Child Custody / Q000331:legislation & jurisprudence; D004353:Drug Evaluation, Preclinical; D005314:Embryonic and Fetal Development / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000523:psychology*; D011295:Prenatal Care; D011297:Prenatal Exposure Delayed Effects; D011640:Public Policy; D012307:Risk Factors; D012959:Socioeconomic Factors; D019966:Substance-Related Disorders / Q000150:complications*; D014481:United States